Stock Research for MDXG

MDXG

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

MDXG Stock Chart & Research Data

The MDXG chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MDXG chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


MDXG Due diligence Resources & Stock Charts

The MDXG stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View MDXG Detailed Price Forecast - CNN Money CNN View MDXG Detailed Summary - Google Finance
Yahoo View MDXG Detailed Summary - Yahoo! Finance Zacks View MDXG Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View MDXG Trends & Analysis - Trade-Ideas Barrons View MDXG Major Holders - Barrons
NASDAQ View MDXG Call Transcripts - NASDAQ Seeking View MDXG Breaking News & Analysis - Seeking Alpha
Spotlight View MDXG Annual Report - CompanySpotlight.com OTC Report View MDXG OTC Short Report - OTCShortReport.com
TradeKing View MDXG Fundamentals - TradeKing Charts View MDXG SEC Filings - Bar Chart
WSJ View Historical Prices for MDXG - The WSJ Morningstar View Performance/Total Return for MDXG - Morningstar
MarketWatch View the Analyst Estimates for MDXG - MarketWatch CNBC View the Earnings History for MDXG - CNBC
StockMarketWatch View the MDXG Earnings - StockMarketWatch MacroAxis View MDXG Buy or Sell Recommendations - MacroAxis
Bullish View the MDXG Bullish Patterns - American Bulls Short Pains View MDXG Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View MDXG Stock Mentions - StockTwits PennyStocks View MDXG Stock Mentions - PennyStockTweets
Twitter View MDXG Stock Mentions - Twitter Invest Hub View MDXG Investment Forum News - Investor Hub
Yahoo View MDXG Stock Mentions - Yahoo! Message Board Seeking Alpha View MDXG Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for MDXG - SECform4.com Insider Cow View Insider Transactions for MDXG - Insider Cow
CNBC View MDXG Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for MDXG - OTC Markets
Yahoo View Insider Transactions for MDXG - Yahoo! Finance NASDAQ View Institutional Holdings for MDXG - NASDAQ


Stock Charts

FinViz View MDXG Stock Insight & Charts - FinViz.com StockCharts View MDXG Investment Charts - StockCharts.com
BarChart View MDXG Stock Overview & Charts - BarChart Trading View View MDXG User Generated Charts - Trading View




Latest Financial News for MDXG


Short-Selling Is Really Hard. Just Ask Citron Research
Posted on Friday February 22, 2019

Examining the influential short-sellers' big winners and losers provides important insights into trading and investing.


[$$] Sen. Johnny Isakson Called FBI on Behalf of MiMedx Group
Posted on Thursday December 27, 2018

Sen. Johnny Isakson, a Georgia Republican, called the Federal Bureau of Investigation in October 2017 to follow up on a complaint lodged by Parker “Pete” Petit, the founder of biomedical company MiMedx Group against an investor who criticized the company and Mr. Petit. Mr. Petit had complained to the FBI and Mr. Isakson called the FBI to ask that they respond to the complaint, his spokeswoman confirmed, adding that Mr. Isakson didn’t request a specific outcome. Seven weeks later, the investor, Marc Cohodes, received a visit from two FBI agents who told him that if he didn’t stop posting negative tweets about Mr. Petit and MiMedx, “there would be consequences,” he told The Wall Street Journal.


Today's Research Reports on Trending Tickers: MiMedx Group and Tandem Diabetes Care
Posted on Wednesday December 12, 2018

NEW YORK, NY / ACCESSWIRE / December 12, 2018 / U.S. equities finished lower on Tuesday after bouncing between the red and green territory. The stocks gained more than 1% across the board on improving ...


MiMedx Announces Resignation Of Outside Auditor
Posted on Wednesday December 05, 2018

MARIETTA, Ga., Dec. 5, 2018 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that on December 4, 2018, Ernst & Young LLP informed the Company's Audit Committee that it has resigned from the engagement to audit the Company's financial statements for the years ended December 31, 2017 and 2018, effective immediately. MiMedx® is a leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary PURION® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.